Ceramics expansion Lucideon is actively pursuing a major £500m investment to establish ceramic matrix composite manufacturing capability in the UK, signaling a potential opportunity to engage in materials development, process optimization, and supply-chain collaboration around high-value ceramics and CMC production.

Global facilities With state-of-the-art facilities in the UK and US and a focus on cross-industry applications (Healthcare, Aerospace, Nuclear, Energy, Construction), there is a clear avenue to position Lucideon as a partner for multi-site R&D programs, scale-up projects, and cross-border qualification services.

Biocompatibility focus The establishment of a biocompatibility lab in Greenville and ongoing biomedical-oriented activities point to opportunities in medical device materials testing, regulatory-ready material analysis, and collaboration on biocompatible ceramics and composites for healthcare applications.

ESA and space Participation in European Space Agency funded programs to advance Flash Sintering for lunar regolith processing indicates readiness to collaborate on advanced ceramics processing, sustainable construction materials, and in-situ resource utilization projects with space/defense contractors or aerospace firms.

Partnership potential Recent collaboration announcements with Metalysis and other EU partners highlight an openness to consortia and joint development efforts, suggesting sales opportunities to engage in integrated programs covering ceramics processing, electrochemistry, and powder metallurgy for advanced manufacturing technologies.